Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2017
Cash flows from operating activities:
Net income	$ 24,494	$ 2,420	$ 18,241
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	10,298	10,498	10,080
Amortization of capitalized software costs	11,338	6,518	7,892
Amortization of other intangibles	21,496	23,380	22,462
Amortization and write-off of debt issuance costs	710	1,610	1,076
Provision for bad debts	5,644	5,913	5,082
Provision for (recovery of) inventory obsolescence	(10)	51	418
Share-based compensation	16,102	12,297	7,598
Deferred income taxes	245	312	(129)
Excess tax deficiency (benefit) from share-based compensation	(365)	328
Change in fair value of contingent consideration	1,000		4,247
Restructuring costs, net of amounts paid			2,891
Impairment of assets		3,757
Loss on disposal of equipment and improvements	194	169	530
Changes in assets and liabilities, net of amounts acquired:
Accounts receivable	(6,178)	(5,409)	5,535
Contract assets	812
Inventory	70	(73)	(21)
Accounts payable	1,070	(1,232)	(6,590)
Contract liabilities	(4,131)	847	(5,493)
Accrued compensation and related benefits	(2,992)	2,228	5,237
Income taxes	4,049	(8,530)	34,740
Deferred compensation	(181)	(543)	272
Other assets and liabilities	(31,566)	19,502	(3,880)
Net cash provided by operating activities	50,475	74,043	110,188
Cash flows from investing activities:
Additions to capitalized software costs	(20,571)	(18,865)	(8,249)
Additions to equipment and improvements	(4,952)	(9,801)	(12,165)
Proceeds from sales and maturities of marketable securities			9,291
Payments for acquisitions, net of cash acquired		(62,867)
HealthFusion working capital adjustment payment			(282)
Net cash used in investing activities	(25,523)	(91,533)	(11,405)
Cash flows from financing activities:
Proceeds from line of credit	26,000	50,000
Repayments on line of credit	(52,000)	(28,000)	(90,000)
Payment of debt issuance costs		(1,105)
Payment of contingent consideration related to acquisitions		(18,817)
Proceeds from issuance of shares under employee plans	7,533	4,889	1,310
Payments for taxes related to net share settlement of equity awards	(3,181)	(848)
Net cash provided by (used in) financing activities	(21,648)	6,119	(88,690)
Net increase (decrease) in cash, cash equivalents, and restricted cash	3,304	(11,371)	10,093
Cash, cash equivalents, and restricted cash at beginning of period	31,218	42,589	32,496
Cash, cash equivalents, and restricted cash at end of period	34,522	31,218	42,589
Supplemental disclosures of cash flow information:
Cash paid for income taxes	1,570	6,379	4,800
Cash refunds from income taxes	675	1,874	29,575
Cash paid for interest	1,819	1,953	1,958
Common stock issued for settlement of share-based contingent consideration			9,273
Non-cash investing and financing activities:
Non-cash additions to capitalized software	2,304
Accrued purchases of equipment and improvements	$ 149	$ 72	$ 82